The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from a phase I/Ib trial of enzalutamide and gemcitabine and cisplatin in metastatic bladder cancer (mBC).
 
Shilpa Gupta
Stock and Other Ownership Interests - Nektar
Honoraria - Janssen Oncology
Consulting or Advisory Role - Exelixis; Genentech; Janssen Oncology; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Astellas Medivation (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst)
 
Jasreman Dhillon
No Relationships to Disclose
 
Anthony Martin Magliocco
Stock and Other Ownership Interests - Proscia; Protean Biodiagnostics; The Genomic Cancer Institite
Honoraria - Bristol-Myers Squibb; illumina; Leica Biosystems; Merck
Consulting or Advisory Role - Bristol-Myers Squibb; illumina; Merck; Proscia; Roche
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Biotheranostics; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Various patents pending as co inventor through Moffitt Cancer Center
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Illumina; Menarini Silicon Biosystems; Merck; Ventana Medical Systems
 
John Puskas
No Relationships to Disclose
 
Gisela Caceres
No Relationships to Disclose
 
Fadzai Masawi
No Relationships to Disclose
 
Yulia Doronin
No Relationships to Disclose
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Sanofi
Speakers' Bureau - AstraZeneca/MedImmune; Sanofi
Research Funding - Astellas Medivation (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst)